Pages that link to "Q73307145"
Jump to navigation
Jump to search
The following pages link to Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma (Q73307145):
Displaying 9 items.
- Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes (Q24622260) (← links)
- Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model (Q24669799) (← links)
- Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors (Q28208139) (← links)
- Quantitative analysis of a panel of gene expression in prostate cancer--with emphasis on NPY expression analysis (Q33318669) (← links)
- Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion (Q34979300) (← links)
- Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer (Q35873154) (← links)
- The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer (Q37857947) (← links)
- Expression and distribution of pituitary adenylate cyclase-activating peptide in human prostate and prostate cancer tissues (Q44240030) (← links)
- Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD (Q83853850) (← links)